OPK

Conviction 62HealthcareScan · Wed, Oct 14, 2026

Piercing line

Opko Health, Inc. (OPK) closed at $1.37 (+3.41%) on Oct 14, 2026. Its latest daily candle is a piercing line. Price is below its 50-day and above its 200-day moving average. RSI(14) 35, RS Rating 58, -21.1% from its 52-week high, +7.5% year to date. Sector: Healthcare · Pharmaceutical Preparations.

OPK$1.37+3.41%

ResistanceSupportVol 14

Vol MA14 1.78M

Jul 17Aug 4Aug 21Sep 9Sep 28Oct 14

Why OPK moved

From the StockSetups movers recaps that covered OPK, newest first. A recap states what was known that day.

Oct 15, 2026Premarket+22.3%
OPKO Health is up 22.3% in premarket, at $1.67, on 21,404,368 shares. Its 20-day average is 2,087,196. It's the largest company on this list, with a market cap near $1.0B.
Premarket Movers Oct 15, 2026: Why WETO, NCPL, DRMA Are Up →

Opko Health, Inc.Pharmaceutical Preparationswww.opko.com ↗

Price1.37

Change+3.41%

Gap-0.76%

Rel volume0.63×

Avg volume2.09M

Avg $ vol3.27M

SMA 201.55

SMA 501.51

SMA 2001.33

Price vs 50-9.42%

Price vs 200+2.99%

MA stackmixed

50/200 cross—

Supertrenddown · 1.52

RSI (14)35

MACD hist-0.03

MACD cross—

Stoch %K / %D16 / 9

ADX (14)33

+DI / −DI15 / 32

RSI divergenceBearish

MACD divergenceBearish

ATR %4.52%

ADR %3.60%

52w high1.73

52w low1.10

From 52w high-21.10%

Above 52w low+24.09%

New 52w highNo

SqueezeOff

Bollinger width33.56%

%B0.15

Donchian pos12.50%

Donchian high1.75

Donchian low1.31

AVWAP (52w high)1.55

vs AVWAP high-11.91%

AVWAP (52w low)1.42

vs AVWAP low-3.74%

OBV trendDown

Chaikin MF (20)-0.07

Today vs 20d0.63×

Avg vol (14d)1.78M

Avg vol (20d)2.09M

Avg $ vol (20d)3.27M

Market cap1.02B

RS Rating58 / 99

RS 3m (vs SPY)+12.18%

RS 6m (vs SPY)+5.72%

RS line new highNo

Trend template6/8

Technical rank56.0

1 week-1.80%

1 month-13.06%

3 months+14.71%

6 months+15.68%

1 year-9.60%

YTD+7.48%

P/E-4.51

P/B0.86

P/S1.68

P/FCF-5.34

EPS-0.3000

Div yield—

ROE-19.06%

ROA-12.34%

Debt/Eq0.00

Current3.35

EV/EBITDA-27.95

Gross margin33.93%

Net margin-37.19%

Rev growth-14.90%

EPS growth-324.02%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value720.67M

Revenue163.58M

Net income-8.42M

Gross profit80.02M

Free cash flow-190.82M

IndustryPharmaceutical Preparations

ExchangeNasdaq

Shares out755.09M

Employees2.27K

ListedThu, Nov 2, 1995

Free float330.12M

Float %43.5%

Short interest34.56M

Days to cover13.8d

Short volume47.9%

Squeeze score51 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.01 vs −$0.08

Last surprise+87.5% beat

Setup gradeB

Conviction62 / 100

Pattern quality—

Tech rank56.0 / 100

Group rank14 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmPiercing line

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in OPK

All disclosures →

No recent disclosed trades by Congress in OPK. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in OPK

Insider	Side	Shares	Value	Traded	Filed
Logal Adam Sr. Vice President, CFO · Common Stock · 2026-07-24	Tax	53.27K	$65K	2026-07-24	2026-07-28
Rubin Steven D Executive VP-Administration · Common Stock · 2026-07-24	Tax	53.27K	$65K	2026-07-24	2026-07-28
MEDEL ROGER MD Director · Stock Option (Right to Buy) · 2026-06-18	Grant	30K	—	2026-06-18	2026-06-22
UPPALURI SUBBARAO V Director · Stock Option (Right to Buy) · 2026-06-18	Grant	80K	—	2026-06-18	2026-06-22
Lachman Prem A Director · Stock Option (Right to Buy) · 2026-06-18	Grant	30K	—	2026-06-18	2026-06-22
Yu Alice Lin-Tsing Director · Stock Option (Right to Buy) · 2026-06-18	Grant	30K	—	2026-06-18	2026-06-22
PFENNIGER RICHARD C JR Director · Stock Option (Right to Buy) · 2026-06-18	Grant	60K	—	2026-06-18	2026-06-22
PAGANELLI JOHN A Director · Stock Option (Right to Buy) · 2026-06-18	Grant	30K	—	2026-06-18	2026-06-22

SEC filings

EDGAR filings in OPK · 9 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.

OPK

Why OPK moved

Recent news

Get daily signals & real-time alerts.